Maligne Gehirntumoren

  • B. Müller
  • M. Bamberg
  • P. Krauseneck

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bamberg M (1993) Zentralnervensystem. In: Dold U, Hermanek P, Hoffken K, Sack H (Hrsg) Praktische Tumortherapie. 4. Aufl. Thieme, Stuttgart — New York 565–598Google Scholar
  2. 2.
    Bamberg M, Budach V, Stuschke M (1986) Preliminary experimental results with the nitrosourea derivate ACNU in the treatment of malignant gliomas. Radiotherapy and OncologyGoogle Scholar
  3. 3.
    Bamberg M, Hess CF (1992) Radiation therapy of malignant gliomas. Onkologie 15: 178–189CrossRefGoogle Scholar
  4. 4.
    Bloom HJG, Glees J, Bell J (1990) Intracranial tumours: response and resistance to therapeutic endeavours 1970–1980. Int J Radiat Oncol Biol Phys 18: 723–745PubMedCrossRefGoogle Scholar
  5. 5.
    Borgelt B, Gelber R, Larson M, Hendrickson F, Griffin T, Roth R (1981) Ultrarapid high dose irradiation schedules for the paliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 7: 1633–1638Google Scholar
  6. 6.
    Chamberlain M, Levin VA (1993) Primary central nervous lymphoma: A role for chemotherapy. J Neurooncol 14: 271–275Google Scholar
  7. 7.
    DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphomas. J Clin Oncol 10: 635–643PubMedGoogle Scholar
  8. 8.
    EORTC Brain Tumor Group (1978) Effekt of CCNU on survival rate of objective remisson and duration of free interval in patients with malignant brain glioma — final evaluation. Europ J Cancer 14: 851–855Google Scholar
  9. 9.
    EORTC Brain Tumor Group (1983) Misonidazole in radiotherapy of supratentorial malignant gliomas in adult patients: A randomized double blind study. Eur J Cancer Clin Oncol 19: 39–42CrossRefGoogle Scholar
  10. 10.
    Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non aids primary central nervous lymphoma. J Neurosurg 70: 190–194PubMedCrossRefGoogle Scholar
  11. 11.
    Göbel U, Bamberg M, Calaminus G, Gnekow AK, Herman HD, Lenard HG, Spar HJ, Niethammer D, Kühl J, Harms D (1993) Verbesserte Prognose intracranialer Keimzelltumoren durch intensivierte Therapie: Ergebnisse des Therapieprotokolls MAKEI 89. Klin Pädiatr 205: 217–224PubMedCrossRefGoogle Scholar
  12. 12.
    Gonzalez DG, Schuster-Uitterhoue ALJ (1983) Primary non-Hodgkin’s lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048–2052PubMedCrossRefGoogle Scholar
  13. 13.
    Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, Mealey J Jr, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR Jr (1983) Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 67: 123–132Google Scholar
  14. 14.
    Grisold W, Weiss R, Jellinger K (1984) Klinik und zytologische Diagnostik der meningealen Neoplasien. In: von Heyden HW, Krauseneck P (Hrsg) Aktuelle Onkologie 13 — Hirnmetastasen. Zuckschwert. München Bern Wien. 85–103Google Scholar
  15. 15.
    Helle TL, Britt RH, Colby TC (1984) Primary lymphoma of the cerebral nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 60: 94–103Google Scholar
  16. 16.
    Henry JM, Heffner RR Jr, Dillard SH et a. (1974) Primary malignant lymphomas of the central nervous system. Cancer 34: 1293–1302PubMedCrossRefGoogle Scholar
  17. 17.
    Hochberg FH, Loffler JS, Prados M (1991) The therapy of primary brain lymphoma. J Neurooncol 10: 191–201PubMedCrossRefGoogle Scholar
  18. 18.
    Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68: 835–853PubMedCrossRefGoogle Scholar
  19. 19.
    Holoye PY, Libnoch JA, Anderson T, Cox JD, Byhardt RW, Hoffmann RG (1985) Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma. Cancer 55: 1436–1445PubMedCrossRefGoogle Scholar
  20. 20.
    Janisch W, Schreiber D, Güthert H (1988) Neuropathologie — Tumore des Nervensystems. Gustav Fischer, Stuttgart New YorkGoogle Scholar
  21. 21.
    Jellinger K (1987) Pathology of Human Intracranial Neoplasia. In: Jellinger K (ed) Therapy of Malignant Brain Tumors. Springer, Wien New York, 1–90CrossRefGoogle Scholar
  22. 22.
    Kleihues P, Burger PC, Scheithauer BW (1993) Histological typing of tumours of the Central Nervous System, Springer Verlag BerlinGoogle Scholar
  23. 23.
    Kreuser ED, Herrmann R, Krauseneck P, Mende S, Thiel E (1991) Systemische Therapie zerebraler Metastasen beim Mammakarzinom. DMW 116: 1203–1207CrossRefGoogle Scholar
  24. 24.
    Lee JS, Murphy WK, Glisson BS, Dhingra HM, Holoye PY, Hong WK (1989) Primary chemotherapy of brain metastasis in small-cell lung cancer. J Clin Oncol 7: 916–922PubMedGoogle Scholar
  25. 25.
    Müller B, Bamberg M, Krauseneck P (1993) Maligne Gehirntumoren. In: Seeber S, Schütte J (Hrsg) Therapiekonzepte Onkologie. 1. Auflage Springer, Berlin Heidelberg New York, 316–330CrossRefGoogle Scholar
  26. 26.
    Mundinger F (1987) Stereotactic biopsy and technique of implantation (instillation) of radionuclids. In: Jellinger K (ed) Therapy of malignant brain tumors. Springer, Wien New York, 134–194CrossRefGoogle Scholar
  27. 27.
    Rosner D, Nemoto T, Pickren J, Lane W (1983) Management of brain metastasis from breast cancer by combination chemotherapy. Neuro-Oncology 2: 2Google Scholar
  28. 28.
    Rustin GJS, Bagshawe KD, Begent RHJ, Crawford SM (1986) Successful management of metastatic and primary germ cell tumors in the brain. Cancer 57: 2108–2113PubMedCrossRefGoogle Scholar
  29. 29.
    Sauer R (1987) Radiation therapy of brain tumors. In: Jellinger K (ed) Therapy of malignant brain tumors. Springer, Wien New York, 195–276CrossRefGoogle Scholar
  30. 30.
    Schlegel U, Krauseneck P (1994) Neue Entwicklungen in der Chemotherapie von Hirntumoren. Akt Neurol 21: 39–46CrossRefGoogle Scholar
  31. 31.
    Seier FE, Demuth K, Müller B, Krauseneck P (1991) Chemotherapie von Hirnmetastasen bei Bronchialkarzinomen. Verh der dt Ges f Neurologie 6: 424–425Google Scholar
  32. 32.
    Shapiro WR, Green SB (1987) Reevaluating the efficacy of intra-arterial BCNU [letter]. J Neurosurg 66: 313–315PubMedGoogle Scholar
  33. 33.
    Shapiro WR, Green SB, Burger PC, Mahaley MD Jr, Selker RG, Gilder JC van, Robertson JT, Ransohoff J, Mealey J Jr, Strike TA, Pistenmaa DA (1989) Randomiz-ed trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Trial 8001. J Neurosurg 71: 1–9PubMedCrossRefGoogle Scholar
  34. 34.
    Stewart DJ, Maroun JA, Hugenholtz H, Benoit B, Girard A, Richard M, Russel N, Huebsch L, Draouin J (1987) Combined intraommaya methotrexate, cytosinearabinoside, hydrocortisone and thio-TEPA for meningeal involvement of malignancies. J Neurooncol 5: 315–322PubMedCrossRefGoogle Scholar
  35. 35.
    Strik H, Müller B, Bogdahn U, Krauseneck P (1992) Management of primary cerebral lymphoma. Cancer Res Clin Oncol 118 (Suppl): Ri 16 (Abstr)Google Scholar
  36. 36.
    Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H, Nishimoto A, Uozmi T, Matsutani M, Nomura K (1986) Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 64: 53–57PubMedCrossRefGoogle Scholar
  37. 37.
    Trojanowski T, Peszynski J, Turowski K, Kaminski S, Goscinski I, Reinfus M, Krzyszkowski T, Pyrich M Bielawski A, Leszczyk C et al. (1988) Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas. J Neurooncol 6: 285–291PubMedCrossRefGoogle Scholar
  38. 38.
    Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Norrell HA, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49: 333–343PubMedCrossRefGoogle Scholar
  39. 39.
    Walker MD, Green SB, Byar DP, Alexander E JR, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J, Robertson T, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323–1329PubMedCrossRefGoogle Scholar
  40. 40.
    Whitton AC, Bloom HJG (1990) Low grade glioma of the cerebral hemispheres in adults: A retorspective analysis of 88 cases. Int J Radiat Oncol Biol Phys 18: 783–786PubMedCrossRefGoogle Scholar
  41. 41.
    Wiestler OD, Wolf HK (1995) Die revidierte WHO-Klassifikation und neue Entwicklungen in der Diagnostik zentralnervöser Tumoren. Pathologe 16: im DruckGoogle Scholar
  42. 42.
    Zülch KJ (1979) Histological typing of tumours of the central nervous system. WHO, GenfGoogle Scholar
  43. 43.
    Müller B, Krauseneck P (1994) Lung-fibrosis — avoided with ACNU instead of BCNU. J Neurooncol 21: 1, 72Google Scholar
  44. 44.
    Cianfriglia F, Pompili A, Riccio A and Grassi A (1980) CCNU-Chemotherapy of hemispheric supratentorial glioblastoma multiforme. Cancer 45: 1289–1299PubMedCrossRefGoogle Scholar
  45. 45.
    Krauseneck P, Müller B, Köpcke W, Messerer D, Aydemir Ü, Kleihues P and Wiestler 0 (1991) Postoperative Strahlen-und Chemotherapie mit BCNU und BCNU+VM26 bei malignen supratentoriellen Gliomen des Erwachsenenalters AbschlußberichtGoogle Scholar
  46. 46.
    Postmus PE, Haaxma-Reiche H, Sleijfer DTh, Kirkpatrick A, McVie JG, Kleistbauer JP and EORTC Lung Cancer Cooperative Group (1989) High dose etoposide for brain metastases of small cell lung cancer — a phase II study. Br J Cancer 59: 254–256CrossRefGoogle Scholar
  47. 47.
    Mahaley MS Jr (1991) Neuro-oncology index and review (adult primary brain tumors). J Neurooncol 11: 85–147PubMedCrossRefGoogle Scholar
  48. 48.
    Mende S, Bleichner F, Stoeter P and Meuret G (1983) Erfolgreiche Behandlung von Hirnmetastasen bei Mamma-Karzinom mit nicht liquorgängigen Zytostatika und Hormonen. Onkologie 6: 58–61PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • B. Müller
  • M. Bamberg
  • P. Krauseneck

There are no affiliations available

Personalised recommendations